11 min read
Monthly FDA Guidance and Regulatory News Review - September 2026
This September 2026 regulatory update focuses on FDA’s new guidance on neonatal parenteral nutrition compounding and...
1 min read
Meet Veristat at the Bio Asia Taiwan 2023 taking place on the 26-30 July 2023
With more than 28 years of experience in clinical trial planning and execution, Veristat is equipped to support any development program.
As you look to transition your compound into clinical trials, you need the right partner to guide your planning and decision-making. Whether you are preparing your IND/CTA, or you are looking to recruit patients quickly to get your early phase trials running, or just need medical writing or biostatistical support for your programs – Veristat can help.
We provide impactful solutions on both a full-service or functional service basis, including strategic regulatory guidance, clinical program design, and IND/CTA support through to successful regulatory approval.
Meet Veristat
Veristat team member Philip Ho , Business Development Director, Asia Pacific, will be at the venue— ready to listen to your needs and share Veristat’s expertise
Schedule A Meeting
Schedule a meeting by filling out the form on the right. Find out how we can help you advance your next clinical trial or regulatory submission to successful outcomes.
Conference Details
Website: Bio Asia Taiwan